Investigation of SMAD3 and SMAD4 genes expression in CML patients and K562 cell line and association with chronic myeloid leukemia

Authors

Abstract:

Aim and Background: Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder with cytogenetic characterization of the abnormal Philadelphia chromosome. This chromosome results from a reciprocal translocation between chromosomes 9 and 22. This is an important signaling pathway in the process of cancer cell proliferation and apoptosis, as well as the pathogenesis of TGF-β disease, in which the absence of gene expression regulation of its components, such as the SMAD family, plays a major role in tumor growth and cancer development. Therefore, the expression of genes SMAD3 and SMAD4 in CML patients and the K562 cell line was compared to the control group in this study, so that their involvement in the disease could be understood and exploited in therapeutic purposes. Materials and methods: In this descriptive study, the expression of genes SMAD3 and SMAD4 was measured by Real Time PCR technique and cDNA synthesis, and GraphPad prism software version 9.3.1 was used to analyze the data collected. Results: In the CML patients and also K562 cell line, SMAD3 gene expression was significantly reduced, while SMAD4 gene expression had no significant relationship with the disease (p <0.05). Conclusion: The expression of specific genes in the signaling pathway, according to this study, can play an effective role in the development of disease or drug resistance. Decreased SMAD3 expression in CML could indicate a relationship between disease and altered gene expression. Therefore, further investigations are needed in order to identify the accurate mechanism of these alterations and their association with the disease.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran

Background: A specific chromosomal abnormality, the Philadelphia chromosome (BCR-ABL fusion), is present in all patients with chronic myeloid leukemia (CML). The b2a2 and b3a2 fusion mRNAs encode p210 fusion protein p210 and e1a2 encode p190. The aim of this study was to evaluate the frequency of BCR-ABL fusion transcript variants in Northeast of Iranian CML patients and to compare the laborato...

full text

quantitative evaluation of imatib efflux and influx transporters expression in chronic myeloid leukemia (cml) patients

objective: in this study quantitative expression of mdr1 and hoct1 genes in cml patients and normal people were measured using real-time pcr. materials and methods: to study quantitative expression of these genes by real-time pcr, master-mix with syber green was used. peripheral blood samples from 30 cml patients and 27 normal persons were harvested. real-time pcr results were analyzed with re...

full text

appearance and disappearance of chronic myeloid leukemia (cml) in patient with chronic lymphocytic leukemia (cll).

chronic lymphocytic leukemia (cll) and chronic myeloid leukemia (cml) are the most common leukemias of the elderly (>43 year). however, the sequential occurrence of cml followed by cll in the same patient is extremely rare. in our report, a 52-year-old female was diagnosed with cll (type of bone marrow (bm) infiltration was nodular and interstitial) and was treated with chlorambucil. 64 months ...

full text

Analysis of Expression Of SIRT1 Gene In Patients With Chronic Myeloid Leukemia Resistant To Imatinib Mesylate

Background: Chronic myeloid leukemia is a clonal myeloproliferative disease which is characterized by bcr/abl translocation. With the emergence of tyrosine kinase inhibitors such as imatinib mesylate, significant improvement has been made in treatment of this disease. However, drug resistance against this medicine is still an obstacle. SIRT1 is a gene with deacetylase activity which has been de...

full text

Study of STAT3 Expression in Different Phases of Patients with Chronic Myeloid Leukemia

Background and Aim: Chronic myeloid leukemia(CML) is a clonal myeloproliferative disease, characterized by BCR/ABL translocation. Using tyrosine kinase inhibitors such as Imatinib, treatment for this disease has progressed remarkably. However, resistance to tyrosine kinase inhibitor is a major obstacle. Signal transducer and activator of transcription 3(STAT3) is an important transcription fact...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 28  issue 3

pages  0- 0

publication date 2023-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023